Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Genzyme reports 2-year data from phase II Gaucher's disease trial

Feb. 16, 2010

4-PBA and curcumin enhance protein expression of mutant ATP7B / News in Context

Feb. 16, 2010

New MR antagonists discovered at Bayer Schering Pharma

Feb. 15, 2010

Theracos identifies novel sodium/glucose cotransporter inhibitors

Feb. 15, 2010

Penwest initiates phase IIa trial of A-0001 in A3243G mitochondrial DNA point mutation

Feb. 15, 2010

Living Cell Technologies receives government grant for Diabecell

Feb. 12, 2010

Roche reports positive results from phase III clinical program of taspoglutide in diabetes

Feb. 11, 2010

Phase III mipomersen study meets primary endpoint in heFH

Feb. 11, 2010

Bristol-Myers Squibb reports the discovery of novel MCH-R1 antagonists

Feb. 11, 2010

Concert Pharmaceuticals describes novel DPP-IV inhibitors

Feb. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...